Our Publications
*Corresponding author
2024
Wooldrage K*, Robbins EC, Duffy SW, Cross AJ. Long-term effects of once-only flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: 21-year follow-up of the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet Gastroenterol Hepatol. 2024; 9: 811–24. doi: 10.1016/S2468-1253(24)00190-0.
Murphy G*, Freedman ND, Abnet CC, et al. Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO. Helicobacter. 2024; 29:e13053. doi:10.1111/hel.13053.
Power S*, Wooldrage K, Saunders BP, et al. The impact of endoscopist performance and patient factors on distal adenoma detection and colorectal cancer incidence. BMC Gastroenterol 24, 44 (2024). doi:10.1186/s12876-024-03125-x.
2023
Sanikini H, Biessy C, Rinaldi S, Navionis AS, Gicquiau A, Keski-Rahkonen P, Kiss A, Weinstein SJ, Albanes D, Agudo A, Jenab M, Riboli E, Gunter MJ, Murphy G, Cross AJ. Circulating hormones and risk of gastric cancer by subsite in three cohort studies. Gastric Cancer. 2023 Nov;26(6):969-987. doi:10.1007/s10120-023-01414-0.
Robbins EC, Wooldrage K, Saunders BP, Cross AJ. PP0980 (Poster) Long-term colorectal cancer incidence, unperturbed by surveillance, among people with no polyps and those with low-risk polyps: an analysis of data from the UK Flexible Sigmoidoscopy Screening Trial. UEG Week 2023; 11(S8):1103-1104. doi:10.1002/ueg2.12461.
2022
15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Pooled Analysis of Randomized Trials. Ann Intern Med. 2022;175:1525-1533. [Epub 11 October 2022]. doi:10.7326/M22-0835.
Author commentary on Amanda J. Cross et al. Endoscopy 2022; 54(10): 31 – 31. DOI: 10.1055/a-1778-9685.
Harewood R*, Wooldrage K, Robbins EC, Kinross J, von Wagner C, Cross AJ. Adenoma characteristics associated with post-polypectomy proximal colon cancer incidence: a retrospective cohort study. Br J Cancer. 2022 Jun;126(12):1744-1754. doi: 10.1038/s41416-022-01719-4.
Cross AJ*, Robbins EC, Pack K, Stenson I, Kirby PL, Patel B, Rutter MD, Veitch AM, Saunders BP, Little M, Gray A, Duffy SW, Wooldrage K. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study. Health Technol Assess 2022 May;26(26) doi: 10.3310/OLUE3796.
Nelson V, Cross AJ, Powell J, Shaw C. Can people living with and beyond colorectal cancer make lifestyle changes with the support of health technology: A feasibility study. J Hum Nutr Diet. 2022 Mar 23. doi: 10.1111/jhn.13008.
Cross AJ*, Robbins EC, Saunders BP, Duffy SW, Wooldrage K. Higher Adenoma Detection Rates at Screening Associated With Lower Long-Term Colorectal Cancer Incidence and Mortality. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e148-e167. doi: 10.1016/j.cgh.2020.09.020.
2021
Cross AJ*, Myles J, Greliak P, Hackshaw A, Halloran S, Benton SC, Addison C, Chapman C, Djedovic N, Smith S, Wagner CV, Duffy SW, Raine R. Including a general practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: Results of a cluster randomised trial. J Med Screen. 2021 Dec;28(4):419-425. doi: 10.1177/0969141321997480.
Cross AJ*, Robbins EC, Pack K, Stenson I, Patel B, Rutter MD, Veitch AM, Saunders BP, Duffy SW, Wooldrage K. Colorectal cancer risk following polypectomy in a multicentre, retrospective, cohort study: an evaluation of the 2020 UK post-polypectomy surveillance guidelines. Gut. 2021 Dec;70(12):2307-2320. doi: 10.1136/gutjnl-2020-323411. Visual abstract also available.
Harewood R*, Disney R, Kinross J, von Wagner C, Cross AJ. Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis. Cancer Causes Control. 2021 Oct;32(10):1047-1061. doi: 10.1007/s10552-021-01472-8.
Robbins EC, Cross AJ*. Reply. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2217-2218. doi: 10.1016/j.cgh.2021.05.061.
Robbins EC, Cross AJ*. Guaiac Fecal Occult Blood Tests and Mortality: A 30-Year Follow-up of Two Pooled Trials. Clin Gastroenterol Hepatol. 2021 May;19(5):892-894. doi: 10.1016/j.cgh.2020.08.029.
Robbins EC, Wooldrage K, Stenson I, Pack K, Duffy S, Weller D, Levin T, Conell C, Wright S, Nickerson C, Martin J, Cross AJ*. Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study. Endoscopy. 2021 Apr;53(4):402-410. doi: 10.1055/a-1217-0155.
Brenner H*, Cross AJ. Merits, Challenges, and Limitations of Randomized Trials on Colorectal Cancer Screening Effectiveness. Gastroenterology. 2021 Mar;160(4):1009-1011. doi: 10.1053/j.gastro.2020.12.029.
Cross AJ*, Robbins EC, Pack K, Stenson I, Patel B, Rutter MD, Veitch AM, Saunders BP, Duffy SW, Wooldrage K. Colorectal cancer risk following polypectomy in a multicentre, retrospective, cohort study: an evaluation of the 2020 UK post-polypectomy surveillance guidelines. Gut. 2021 Mar 5:gutjnl-2020-323411. doi: 10.1136/gutjnl-2020-323411.
Cross AJ, Myles J*, Greliak P, Hackshaw A, Halloran S, Benton SC, Addison C, Chapman C, Djedovic N, Smith S, von Wagner C, Duffy SW, Raine R. Including a General practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: results of a cluster randomised trial (ASCEND 2). J Med Screen. 2021 Feb 27:969141321997480. doi: 10.1177/0969141321997480.
Robbins EC*, Wooldrage K, Saunders BP, Duffy SW, Cross AJ. P22 (Poster) Impact of adenoma detection rates at flexible sigmoidoscopy on long-term colorectal cancer incidence and mortality. doi:10.1136/gutjnl-2020-bsgcampus.97 BSG Virtual campus conference Jan 2021.
Harewood R*, Wooldrage K, Kinross J, von Wagner C, Cross AJ. O56 (Oral presentation). Risk factors for proximal colon cancer: how informative are polyp findings in determining future risk? doi:10.1136/gutjnl-2020-bsgcampus.56 BSG Virtual campus conference Jan 2021.
2020
Brenner H, Cross AJ. Merits, challenges and limitations of randomized trials on colorectal cancer screening effectiveness. Gastroenterology. 2020 Dec 21:S0016-5085(20)35570-0. doi: 10.1053/j.gastro.2020.12.029.
Cross AJ*, Robbins EC, Saunders BP, Duffy SW, Wooldrage K. Higher adenoma detection rates at screening associated with lower long-term colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2020 Sep 12:S1542-3565(20)31280-5. doi: 10.1016/j.cgh.2020.09.020.
Robbins EC, Cross AJ. Guaiac fecal occult blood tests and mortality: A 30-year follow-up of two pooled trials. Clin Gastroenterol Hepatol. 2020 Aug 13:S1542-3565(20)31138-1. doi: 10.1016/j.cgh.2020.08.029.
Rutter MD, Bretthauer M, Hassan C, Jover R; WEO Surveillance Working Group (includes Cross AJ). Principles for Evaluation of Surveillance After Removal of Colorectal Polyps: Recommendations from the World Endoscopy Organization. Gastroenterology. 2020 May;158(6):1529-1533.e4. doi: 10.1053/j.gastro.2019.12.052.
Robbins EC, Wooldrage K, Cross AJ*. Is surveillance colonoscopy necessary for all patients with bowel polyps? BMJ. 2020 May 15;369:m1706. doi: 10.1136/bmj.m1706.
Bright CJ*, Brentnall AR, Wooldrage K, Myles J, Sasieni P, Duffy SW. Errors in determination of net survival: cause-specific and relative survival settings. Br J Cancer. 2020 Mar;122(7):1094-1101. doi: 10.1038/s41416-020-0739-4.
Cross AJ*, Robbins EC, Pack K, Stenson I, Kirby PL, Patel B, Rutter MD, Veitch AM, Saunders BP, Duffy SW, Wooldrage K. Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut 2020 Jan 17. pii: gutjnl-2019-320036. doi: 10.1136/gutjnl-2019-320036.
2019
Rutter MD*, East J, Rees CJ, et al. Rutter MD, East J, Rees CJ, Cripps N, Docherty J, Dolwani S, Kaye PV, Monahan KJ, Novelli MR, Plumb A, Saunders BP, Thomas-Gibson S, Tolan DJM, Whyte S, Bonnington S, Scope A, Wong R, Hibbert B, Marsh J, Moores B, Cross A, Sharp L. (AC and LS are joint senior authors). British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 2019 Nov 27; 0:1–23. doi:10.1136/gutjnl-2019-319858
Gunter MJ*, Alhomoud S, Arnold M, Brenner H, Burn J, Casey G, Chan AT, Cross AJ, Giovannucci E, Hoover R, Houlston R, Jenkins M, Laurent-Puig P, Peters U, Ransohoff D, Riboli E, Sinha R, Stadler ZK, Brennan P, Chanock SJ. Meeting Report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer. Ann Oncol. 2019 Apr 1;30(4):510-519. doi: 10.1093/annonc/mdz044.
Atkin W, Cross AJ*, Kralj-Hans I, MacRae E, Piggott C, Pearson S, Wooldrage K, Brown J, Lucas F, Prendergast A, Marchevsky N, Patel B, Pack K, Howe R, Skrobanski H, Kerrison R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran S. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study. NIHR Journals Library: Health Technology Assessment 23(1). doi: 10.3310/hta23010
2018
Cross AJ*, Wooldrage K, Robbins EC, Pack K, Brown JP, Hamilton W, Thompson MR, Flashman KG, Halligan S, Thomas-Gibson S, Vance M, Saunders BP, Atkin W. Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study. Br J Cancer doi: 10.1038/s41416-018-0335-z.
Cross AJ*, Wooldrage K, Robbins EC, Kralj-Hans I, MacRae E, Piggott C, Stenson I, Prendergast A, Patel B, Pack K, Howe R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran SP, Atkin WS. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study. GUT. doi: 10.1136/gutjnl-2018-317297
Pinsky PF*, Loberg M, Senore C, Wooldrage K, Atkin W, Bretthauer M, Cross AJ, Hoff G, Holme O, Kalager M, Segnan N, Schoen RE. Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening. Gastroenterology. 2018 Jun 20. pii: S0016-5085(18)34667-5. doi: 10.1053/j.gastro.2018.06.040. Epub 2018 Jun 20 PMID:29935150
Brown JP*, Wooldrage K, Kralj-Hans I, Wright S, Cross AJ, Atkin WS. Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening. J Med Screen. 2018 Oct 3:969141318785654. doi: 10.1177/0969141318785654. [Epub ahead of print] PMID: 30282520
2017
Atkin W*, Wooldrage K, Shah U, Skinner K, Brown JP, Hamilton W, Kralj-Hans I, Thompson MR, Flashman KG, Halligan S, Thomas-Gibson S, Vance M, Cross AJ. Is whole-colon investigation by colonoscopy, computerised tomography colonography or barium enema necessary for all patients with colorectal cancer symptoms, and for which patients would flexible sigmoidoscopy suffice? A retrospective cohort study. Health Technol Assess. 21(66):1-80. doi: 10.3310/hta21660.PMID: 29153075
Atkin W*, Brenner A, Martin J, Wooldrage K, Shah U, Lucas F, Greliak P, Pack K, Kralj-Hans I, Thomson A, Perera S, Wood J, Miles A, Wardle J, Kearns B, Tappenden P, Myles J, Veitch A, Duffy SW. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations. Health Technol Assess. 2017 Apr;21(25):1-536. doi: 10.3310/hta21250. PMID: 28621643
Brown JP, Wooldrage K, Wright S, Nickerson C, Cross AJ, Atkin WS*. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy. J Med Screen. 2017 May 3 doi: 10.1177/0969141317698501. PMID: 28467146
Atkin W*, Wooldrage K, Brenner A, Martin J, Shah U, Perera S, Lucas F, Brown JP, Kralj-Hans I, Greliak P, Pack K, Wood J, Thomson A, Veitch A, Duffy SW, Cross AJ. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol. 2017 Jun;18(6):823-834. doi: 10.1016/S1470-2045(17)30187-0. PMID: 28457708
East JE*, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, Leedham SJ, Phull PS, Rutter MD, Shepherd NA, Tomlinson I, Rees CJ. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017 Apr 27 doi: 10.1136/gutjnl-2017-314005. PMID: 28450390
Raine R*, Atkin W, von Wagner C, Duffy S, Kralj-Hans I, Hackshaw A, Counsell N, Moss S, McGregor L, Palmer C, Smith S G, Thomas M, Howe R, Vart G, Band R, Halloran S P, Snowball J, Stubbs N, Handley G, Logan R, Rainbow S, Obichere A, Smith S, Morris S, Solmi F & Wardle J. Testing innovative strategies to reduce the social gradient in the uptake of bowel cancer screening: a programme of four qualitatively enhanced randomised controlled trials. Southampton (UK): NIHR Journals Library; 2017 Mar PMID: 28375592
Atkin W*, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, Duffy S, Cross AJ. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017 Apr 1;389(10076):1299-1311. doi: 10.1016/S0140-6736(17)30396-3. PMID: 28236467
2016
Raine R*, Moss SM, von Wagner C, Atkin W, Hans IK, Howe R, Solmi F, Morris S, Counsell N, Hackshaw A, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Seaman H, Thomas M, Smith SG, McGregor LM, Vart G, Wardle J, Duffy SW. A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening. Br J Cancer. 2016 Dec 6;115(12):1479-1486. doi: 10.1038/bjc.2016.365. PMID: 27875518
Bonello B, Ghanouni A, Bowyer HL, MacRae E, Atkin W, Halloran SP, Wardle J, von Wagner C* Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy. BMC Gastroenterol. 2016 Sep 13;16:113. doi: 10.1186/s12876-016-0517-1. PMID: 27618798
Subramanian S, Tangka FK, Hoover S, Nadel M, Smith R, Atkin W, Patnick J; International Colorectal Cancer Screening Network. Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs. J Public Health Manag Pract. 2016 Sep-Oct;22(5):461-5. doi: 10.1097/PHH.0000000000000386. PMID: 27479308
McGregor LM, Bonello B, Kerrison RS, Nickerson C, Baio G, Berkman L, Rees CJ, Atkin W, Wardle J, von Wagner C*. Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months. J Med Screen. 2016 Jun;23(2):77-82. doi: 10.1177/0969141315604659. PMID: 26387824
Plumb AA, Nickerson C, Wooldrage K, Bassett P, Taylor SA, Altman D, Atkin W, Halligan S*. Terminal digit preference biases polyp size measurements at endoscopy, computed tomographic colonography, and histopathology. Endoscopy. 2016 Oct;48(10):899-908. doi: 10.1055/s-0042-108727. PMID: 27441685
Plumb AA, Pathiraja F, Nickerson C, Wooldrage K, Burling D, Taylor SA, Atkin WS, Halligan S* Appearances of screen-detected versus symptomatic colorectal cancers at CT colonography. Eur Radiol. 2016 Dec;26(12):4313-4322. DOI: 10.1007/s00330-016-4293-7 PMID: 27048534
McGregor LM*, von Wagner C*, Atkin W, Kralj-Hans I, Halloran SP, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Thomas MC, Smith SG, Vart G, Howe R, Counsell N, Hackshaw A, Morris S, Duffy SW, Raine R and Wardle J. Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial. Gastroenterol Res Pract. 2016;2016:3670150. doi: 10.1155/2016/3670150. PMID: 27069473
Young GP*, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva M, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O’Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865. PMID: 26828588
Raine R, Duffy SW, Wardle J, Solmi F, Morris S*, Howe R, Kralj-Hans I, Snowball J, Counsell N, Moss S, Hackshaw A, von Wagner C, Vart G, McGregor LM, Smith SG, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Atkin W. Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening. Br J Cancer. 2016 Feb 2;114(3):321-6. doi: 10.1038/bjc.2015.413. PMID: 26742011
Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, Vart G, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Counsell N, Morris S, Duffy SW, Hackshaw A, Moss S, Atkin W, Raine R Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials Lancet. 2015 Dec 08
2015
Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, Dean PB, de Koning HJ, Dillner L, Herrero R, Kuipers EJ, Lansdorp-Vogelaar I, Minozzi S, Paci E, Regula J, Törnberg S, Segnan N*. European Code against Cancer, 4th Edition: Cancer Epidemiol. 2015 Dec;39 Suppl 1:S139-52. doi: 10.1016/j.canep.2015.10.021. PMID: 26596722
Halligan S, Wooldrage K, Dadswell E, Shah U, Kralj-Hans I, von Wagner C, Faiz O, Teare J, Edwards R, Kay C, Yao G, Lilford RJ, Morton D, Wardle J, Atkin W; SIGGAR Investigators Identification of Extracolonic Pathologies by Computed Tomographic Colonography in Colorectal Cancer Symptomatic Patients. Gastroenterology. 2015 Jul;149(1):89-101.e5. doi: 10.1053/j.gastro.2015.03.011. Epub 2015 Mar 18.PMID: 25796362
Schüz J*, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, Romieu I, Segnan N, Wardle J, Wiseman M, Belardelli F, Bettcher D, Cavalli F, Galea G, Lenoir G, Martin-Moreno JM, Nicula FA, Olsen JH, Patnick J, Primic-Zakelj M, Puska P, van Leeuwen FE, Wiestler O, Zatonski W, Working Groups of Scientific Experts. European Code against Cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015 Dec;39 Suppl 1:S1-10. doi: 10.1016/j.canep.2015.05.009. PMID: 26164654
MacRae E, Marchevsky N, Brenner A, Patel B, Pearson S, Piggot C, von Wagner C, Wardle J, Halloran S, Atkin W Determining the sensitivity and specificity of annual faecal immunochemical tests for haemoglobin (FIT) compared with findings at surveillance colonoscopy for patients diagnosed with intermediate risk adenomas – the fit for follow-up study. Gut 2015;64:A365
Halligan S, Dadswell E, Wooldrage K, Wardle J, von Wagner C, Lilford R, Yao GL, Zhu S, Atkin W. Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials). Health Technol Assess. 2015 Jul;19(54):1-134. doi: 10.3310/hta19540.PMID: 26198205
2014
MacRae E, Brenner A, Martin J, Pearson S, Piggot C, Bowyer H, Vart G, von Wagner C, Wardle J, Halloran S, Atkin W Sensitivity Of Annual Faecal Immunochemical Tests For Haemoglobin (fit) For Detecting Advanced Neoplasia In Patients Undergoing Three-yearly Surveillance Colonoscopy – The Fit For Follow-up Study. Gut 2014;63:A20-A21
von Wagner C, Bowyer H, Rees CJ, Atkin W, Wardle J Patient-reported Experience Of Comfort And Dignity In Flexible Sigmoidoscopy: Data From The Nhs Bowel Scope Screening Pilot. Gut 2014;63:A137
Zhu S, Yao G, Halligan S, Atkin W, Dadswell E, Wooldrage K, Lilford RJ Cost-Effectiveness Analysis Of Computed Tomographic Colonography Versus Double Contrast Barium Enema For Investigation Of Patients With Symptoms Of Colorectal Cancer: Economic Evaluation Alongside The Siggar Trial. Value in Health 2014 Nov;17(7):A719.
Papadia C, Louwagie J, Del Rio P, Grooteclaes M, Coruzzi A, Montana C, Novelli M, Bordi C, de’ Angelis GL, Bassett P, Bigley J, Warren B, Atkin W, Forbes A. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia. Inflamm Bowel Dis. 2014 Feb;20(2):271-7. doi: 10.1097/01.MIB.0000435443.07237.ed.PMID: 24280874
2013
Robb KA, Lo SH, Power E, Kralj-Hans I, Edwards R, Vance M, von Wagner C, Atkin W, Wardle J. Patient-reported outcomes following flexible sigmoidoscopy screening for colorectal cancer in a demonstration screening programme in the UK. J Med Screen. 2013 Sep 2. [Epub ahead of print] PMID: 23417540 [PubMed – as supplied by publisher]
Atkin W, Halligan S. Computed tomographic colonography for colorectal cancer diagnosis – Authors’ reply. Lancet. 2013 Jul 13;382(9887):125. doi: 10.1016/S0140-6736(13)61558-5. PMID: 23849919
Atkin W, Dadswell E, Wooldrage K, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford RJ, Morton D, Wardle J, Halligan S; SIGGAR investigators. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet. 2013 Apr 6;381(9873):1194-202. doi: 10.1016/S0140-6736(12)62186-2. Epub 2013 Feb 14.PMID: 23414650
Halligan S, Wooldrage K, Dadswell E, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford RJ, Morton D, Wardle J, Atkin W; SIGGAR investigators. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet. 2013 Apr 6;381(9873):1185-93. doi: 10.1016/S0140-6736(12)62124-2. Epub 2013 Feb 14.PMID: 23414648
European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51-9. doi: 10.1055/s-0032-1325997. PMID: 23212726
Bowyer HL, Vart G, Kralj-Hans I, Atkin W, Halloran SP, Seaman H, Wardle J, Wagner Cv. Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer. J Med Screen. 2013;20(3):149-56. doi: 10.1177/0969141313503953. Epub 2013 Sep 17.PMID: 24045920
2012
Irving GR, Howells LM, Sale S, Kralj-Hans I, Atkin WS, Clark SK, Britton RG, Jones DJ, Scott EN, Berry DP, Hemingway D, Miller AS, Brown K, Gescher AJ, Steward WP. Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration–a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila). 2013 Feb;6(2):119-28. doi: 10.1158/1940-6207.CAPR-12-0281. Epub 2012 Dec 11.PMID: 23233733
Martínez ME, Thompson P, Messer K, Ashbeck EL, Lieberman DA, Baron JA, Ahnen DJ, Robertson DJ, Jacobs ET, Greenberg ER, Cross AJ, Atkin W. One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med. 2012 Dec 18;157(12):856-64. doi: 10.7326/0003-4819-157-12-201212180-00005.PMID: 23247939
Valori R, Rey JF, Atkin WS, Bretthauer M, Senore C, Hoff G, Kuipers EJ, Altenhofen L, Lambert R, Minoli G. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition–Quality assurance in endoscopy in colorectal cancer screening and diagnosis. Endoscopy. 2012 Sep;44 Suppl 3:SE88-105. DOI: 10.1055/s-0032-1309795. PMID: 23012124
Atkin WS, Valori R, Kuipers EJ, Hoff G, Senore C, Segnan N, Jover R, Schmiegel W, Lambert R, Pox C. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition–Colonoscopic surveillance following adenoma removal. Endoscopy. 2012 Sep;44 Suppl 3:SE151-63. DOI: 10.1055/s-0032-1309821. PMID: 23012119
Morris S, Baio G, Kendall E, von Wagner C, Wardle J, Atkin W, Halloran SP, Handley G, Logan RF, Obichere A, Rainbow S, Smith S, Snowball J, Raine R. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer. 2012 Aug 21;107(5):765-71. doi: 10.1038/bjc.2012.303. PMID: 22864455
Robb KA, Lo SH, Power E, Kralj-Hans I, Edwards R, Vance M, von Wagner C, Atkin W, Wardle J. Patient-reported outcomes following flexible sigmoidoscopy screening for colorectal cancer in a demonstration screening programme in the UK. J Med Screen. 2012 Dec;19(4):171-6. doi: 10.1258/jms.2012.012129.PMID: 23486697
Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P; International Colorectal Cancer Screening Network. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer. 2012 Jun 15;130(12):2961-73. doi: 10.1002/ijc.26310. Epub 2011 Aug 30.PMID: 21792895
von Wagner C, Ghanouni A, Halligan S, Smith S, Dadswell E, Lilford RJ, Morton D, Atkin W, Wardle J; SIGGAR Investigators. Patient acceptability and psychologic consequences of CT colonography compared with those of colonoscopy: results from a multicenter randomized controlled trial of symptomatic patients. Radiology. 2012 Jun;263(3):723-31. doi: 10.1148/radiol.12111523. Epub 2012 Mar 21.PMID: 22438366
2011
von Wagner C, Smith S, Halligan S, Ghanouni A, Power E, Lilford RJ, Morton D, Dadswell E, Atkin W, Wardle J; SIGGAR Investigators Patient acceptability of CT colonography compared with double contrast barium enema: results from a multicentre randomised controlled trial of symptomatic patients. Eur Radiol. 2011 Oct;21(10):2046-55. doi: 10.1007/s00330-011-2154-y. Epub 2011 May 31.PMID: 21626363
Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C; SCORE Working Group. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22. doi: 10.1093/jnci/djr284. Epub 2011 Aug 18. Erratum in: J Natl Cancer Inst. 2011 Dec 21;103(24):1903. Fracchia, M [added].PMID: 21852264
von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011 Jun;40(3):712-8. doi: 10.1093/ije/dyr008. Epub 2011 Feb 17.PMID: 21330344
Robb KA, Smith SG, Power E, Kralj-Hans I, Vance M, Wardle J, Atkin W. Nurses’ experiences of a colorectal cancer screening pilot. Br J Nurs. 2011 Feb 24-Mar 9;20(4):210, 212, 214 passim.PMID: 21471859
2010
Robb KA, Power E, Kralj-Hans I, Atkin WS, Wardle J. The impact of individually-tailored lifestyle advice in the colorectal cancer screening context: a randomised pilot study in North-West London. Prev Med. 2010 Dec;51(6):505-8. doi: 10.1016/j.ypmed.2010.10.002. Epub 2010 Oct 13.PMID: 20950640
Atkin W, Kralj-Hans I, Wardle J, Duffy S. Colorectal cancer screening. Randomised trials of flexible sigmoidoscopy. BMJ. 2010 Aug 24;341:c4618. doi: 10.1136/bmj.c4618. No abstract available.PMID: 20736284
Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X. Epub 2010 Apr 27.PMID: 20430429
Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR; British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010 May;59(5):666-89. doi: 10.1136/gut.2009.179804. Review.PMID: 20427401
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4. Review.PMID: 20304247
Atkin WS, Benson VS, Green J, Monk CR, Nadel MR, Patnick J, Smith RA, Villain P. Improving colorectal cancer screening outcomes: proceedings of the second meeting of the International Colorectal Cancer Screening Network, a global quality initiative. J Med Screen. 2010;17(3):152-7. doi: 10.1258/jms.2010.010002.PMID: 20956726
Robb K, Power E, Kralj-Hans I, Edwards R, Vance M, Atkin W, Wardle J. Flexible sigmoidoscopy screening for colorectal cancer: uptake in a population-based pilot programme. J Med Screen. 2010;17(2):75-8. doi: 10.1258/jms.2010.010055.PMID: 20660435
Wardle J, Atkin W. Colorectal cancer prevention through screening: population acceptance of flexible sigmoidoscopy. J Med Screen. 2010;17(2):56-7. doi: 10.1258/jms.2010.010062. No abstract available.PMID: 20660431
2009
Austin KL, Power E, Solarin I, Atkin WS, Wardle J, Robb KA. Perceived barriers to flexible sigmoidoscopy screening for colorectal cancer among UK ethnic minority groups: a qualitative study. J Med Screen. 2009;16(4):174-9. doi: 10.1258/jms.2009.009080. PMID: 20054091
von Wagner C, Halligan S, Atkin WS, Lilford RJ, Morton D, Wardle J. Choosing between CT colonography and colonoscopy in the diagnostic context: a qualitative study of influences on patient preferences. Health Expect. 2009 Mar;12(1):18-26. doi: 10.1111/j.1369-7625.2008.00520.x.PMID: 19250149
Miles A, Atkin WS, Kralj-Hans I, Wardle J. The psychological impact of being offered surveillance colonoscopy following attendance at colorectal screening using flexible sigmoidoscopy. J Med Screen. 2009;16(3):124-30. doi: 10.1258/jms.2009.009041. PMID: 19805753
Epstein D, Bojke L, Sculpher MJ; REFLUX trial group. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ. 2009 Jul 14;339:b2576. doi: 10.1136/bmj.b2576. PMID: 19654097
Von Wagner R, Knight K, Halligan S, Atkin W, Lilford R, Morton D, Wardle J. Patient experiences of colonoscopy, barium enema and CT colonography: a qualitative study. Br J Radiol. 2009 Jan;82(973):13-9. doi: 10.1259/bjr/61732956. PMID: 18824501
2008
Thompson MR, Flashman KG, Wooldrage K, Rogers PA, Senapati A, O’Leary DP, Atkin W. Flexible sigmoidoscopy and whole colonic imaging in the diagnosis of cancer in patients with colorectal symptoms. Br J Surg. 2008 Sep;95(9):1140-6. doi: 10.1002/bjs.6234. PMID: 18623058
Power E, Van Jaarsveld CH, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008 Jun;35(3):285-94. doi: 10.1007/s12160-008-9034-y. Epub 2008 Jun 25.PMID: 18575946
Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008 Mar 15;122(6):1357-67.PMID: 18033685
Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health. 2008 Jan 25;8:34. doi: 10.1186/1471-2458-8-34.PMID: 18221519
Robb KA, Power E, Atkin W, Wardle J. Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J Med Screen. 2008;15(3):130-6. doi: 10.1258/jms.2008.007112.PMID: 18927095
2007
Halligan S, Lilford RJ, Wardle J, Morton D, Rogers P, Wooldrage K, Edwards R, Kanani R, Shah U, Atkin W. Design of a multicentre randomized trial to evaluate CT colonography versus colonoscopy or barium enema for diagnosis of colonic cancer in older symptomatic patients: the SIGGAR study. Trials. 2007 Oct 27;8:32.PMID: 17963520 [PubMed]
Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K; CORGI Consortium, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier JB, Houlston R. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007 Aug;39(8):984-8. Epub 2007 Jul 8.PMID: 17618284
Carvajal-Carmona L, Howarth K, Lockett M, Polanco-Echeverry G, Volikos E, Gorman M, Barclay E, Martin L, Jones A, Saunders B, Guenther T, Donaldson A, Paterson J, Frayling I, Novelli M, Phillips R, Thomas H, Silver A, Atkin W, Tomlinson I. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol. 2007 Aug;212(4):378-85. DOI: 10.1002/path.2187. PMID: 17503413
Cafferty FH, Wong JM, Yen AM, Duffy SW, Atkin WS, Chen TH. Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-up. Cancer J. 2007 Jul-Aug;13(4):263-70.PMID: 17762762
Lieberman D, Nadel M, Smith RA, Atkin W, Duggirala SB, Fletcher R, Glick SN, Johnson CD, Levin TR, Pope JB, Potter MB, Ransohoff D, Rex D, Schoen R, Schroy P, Winawer S. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007 May;65(6):757-66. Review.PMID: 17466195
Burling D, Halligan S, Atchley J, Dhingsar R, Guest P, Hayward S, Higginson A, Jobling C, Kay C, Lilford R, Maskell G, McCafferty I, McGregor J, Morton D, Kumar Neelala M, Noakes M, Philips A, Riley P, Taylor A, Bassett P, Wardle J, Atkin W, Taylor SA. CT colonography: interpretative performance in a non-academic environment. Clin Radiol. 2007 May;62(5):424-9; discussion 430-1. DOI: 10.1016/j.crad.2006.11.004. PMID: 17398266
Halligan S, Burling D, Atkin W, Bartram C, Fenlon H, Laghi A, Stoker J, Altman DG, Bassett P, Frost R, Taylor S, Honeyfield L, DeVilliers M, Nicholson D, Renaut L, Kay C, Lowe A, Williams-Butt J, Florie J, Poulus M, Van-der-Hulst V, Lefere P, Marrannes J, Dessey G, Fenlon H, O’Hare A, Foley S, Neri E, Vagli P, Politi B, Iannaccone R. Effect of directed training on reader performance for CT colonography: Multicenter study. Radiology. 2007 Jan;242(1):152-61. DOI: 10.1148/radiol.2421051000. PMID: 17185666
Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop DT, Primrose J, Bingham SA. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis. 2007 Apr;28(4):875-82. Epub 2006 Nov 1.PMID: 17082176
Brotherstone H, Vance M, Edwards R, Miles A, Robb KA, Evans RE, Wardle J, Atkin W. Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study. J Med Screen. 2007;14(2):76-80. PMID: 17626706
2006
Brotherstone H, Miles A, Robb KA, Atkin W, Wardle J. The impact of illustrations on public understanding of the aim of cancer screening. Patient Educ Couns. 2006 Nov;63(3):328-35. Epub 2006 Sep 29.PMID: 17011155
Cotton PB, Barkun A, Ginsberg G, Hawes RH, Atkin W, Bjorkman DJ, Dykes C, Elta G, Farrell J, Fleischer D, Ganz R, Glenn T, Janowski D, Johnson D, Kochman M, Kowalski T, Megibow AJ, McQuaid K, Sasa H, Thompson CC, Vargo J, Woods K. Diagnostic endoscopy: 2020 vision. Gastrointest Endosc. 2006 Sep;64(3):395-8. No abstract available.PMID: 16923489
Arber N, Eagle C, Spicak J, Racz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, McMurray J, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B, (PreSAP) Trial Investigators. Celecoxib for the prevention of sporadic adenomatous polyps. N Engl J Med. 2006 Aug 31;355(9):885-95. DOI: 10.1056/NEJMoa061652. PMID: 16943401
Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop TD, Primrose J, Bingham SA. MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom). Cancer Causes Control. 2006 Aug;17(6):793-801.PMID: 16783607
Thomas-Gibson S, Rogers, PA, Cooper S, Man R, Rutter MD, Suzuki N, Swain D, Thuraisingam A, Atkin W. Judgement of quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates. Endoscopy. 2006 May;38(5):456-60. DOI: 10.1055/s-2006-925259. PMID: 16767579
Thomas-Gibson S, Saunders BP, Suzuki N, Vance M, Rutter M, Swain D, Thapar C, Quraishy S, Nicholls A, Atkin WS. Development of a Video Assessment scoring method to determine the accuracy of Endoscopist performance at screening flexible sigmoidoscopy. Endoscopy. 2006 Mar;38(3):218-25. DOI: 10.1055/s-2005-870445. PMID: 16528646
Burling D, Halligan S, Altman DG, Atkin W, Bartram C, Fenlon H, Laghi A, Stoker J, Taylor S, Frost R, Dessey G, De Villiers M, Florie J, Foley S, Honeyfield L, Iannaccone R, Gallo T, Kay C, Lefere P, Lowe A, Mangiapane F, Marrannes J, Neri E, Nieddu G, Nicholson D, O’Hare A, Ori S, Politi B, Poulus M, Regge D, Renaut L, Rudralingham V, Signoretta S, Vagli P, Van der Hulst V, Williams-Butt J. Polyp measurement and size categorisation by CT colonography: effect of observer experience in a multi-centre setting. Eur Radiol. 2006 Aug;16(8):1737-44. Epub 2006 Apr 25.PMID: 16636803
Burling D, Halligan S, Altman DG, Atkin W, Bartram C, Fenlon H, Laghi A, Stoker J, Taylor S, Frost R, Dessey G, De Villiers M, Florie J, Foley S, Honeyfield L, Iannaccone R, Gallo T, Kay C, Lefere P, Lowe A, Mangiapane F, Marrannes J, Neri E, Nieddu G, Nicholson D, O’Hare A, Ori S, Politi B, Poulus M, Regge D, Renaut L, Rudralingham V, Signoretta S, Vagli P, Van der Hulst V, Williams-Butt J. CT colonography interpretation times: effect of reader experience, fatigue, and scan findings in a multi-centre setting. Eur Radiol. 2006 Aug;16(8):1745-9. Epub 2006 Apr 25.PMID: 16636802
Burling D, Halligan S, Taylor S, Brennand DJ, Altman DG, Bassett P, Atkin W, Bartram CI. Polyp measurement using CT colonography: agreement with colonoscopy and effect of viewing conditions on interobserver and intraobserver agreement. AJR Am J Roentgenol. 2006 Jun;186(6):1597-604.PMID: 16714648
Atkin WS. Impending or pending? The national bowel cancer screening programme. BMJ. 2006 Apr 1;332(7544):742. Epub 2006 Mar 22. No abstract available. PMID: 16554333
Bonelli L, Sciallero S, Senore C, Zappa M, Aste H, Andreoni B, Angioli D, Ferraris R, Gasperoni S, Malfitana G, Pennazio M, Atkin W, Segnan N; SCORE Working Group. History of negative colorectal endoscopy and risk of rectosigmoid neoplasms at screening flexible sigmoidoscopy. Int J Colorectal Dis. 2006 Mar;21(2):105-13. Epub 2005 Apr 28.PMID: 15864604
2005
Halligan S, Altman DG, Taylor SA, Mallett S, Deeks JJ, Bartram CI, Atkin W CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology. 2005 Dec;237(3):893-904. Review.PMID: 16304111
Nicholson F, Barro J, Atkin W, Lilford R, Patnick J, Williams C, et al. Review article: population screening for colorectal cancer. Aliment Pharmacol Ther. 2005 Dec;22(11-12):1069-77. DOI: 10.1111/j.1365-2036.2005.02695.x. PMID: 16305720
Patnick J, Ransohoff D, Atkin W, Borras JM, Elwood M, Hoff G, Nadel M, Russo A, Simon J, Weiderpass-Vaino E, Zappa M, Smith R. Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol. 2005 Jan;16(1):34-7. DOI: 10.1093/annonc/mdi032 PMID: 15598934
Wardle J, Miles A, Atkin W. Gender differences in utilization of colorectal cancer screening. J Med Screen. 2005;12(1):20-7. DOI: 10.1258/0969141053279158 PMID: 15814015
Levin TR, Atkin WS. Colonoscopic screening of women for colorectal neoplasia. N Engl J Med. 2005 Aug 25;353(8):844-6; author reply 844-6. No abstract available.PMID: 16120868
Gunter MJ, Watson MA, Loktionov AS, Mitrou P, Cecil T, Macklin C, Cardwell C, Bishop DT, Primrose J, Atkin WS, Bingham SA. No association between cytochrome P450 and glutathione S-transferase gene polymorphisms and risk of colorectal adenoma: results from the UK Flexible Sigmoidoscopy Screening Trial. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1028-30. No abstract available.PMID: 15824187
Halligan S, Atkin W. Unbiased studies are needed before virtual colonoscopy can be dismissed. Lancet. 2005 Jan 22-28;365(9456):275-6. No abstract available.PMID: 15664205
Levin TR, Farraye FA, Schoen RE, Hoff G, Atkin WS, Bond JH, Winawer SJ, Burt RW, Johnson DA, Kirk LM, Litin SC, Rex DK. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005 Jun;54(6):807-13. DOI: 10.1136/gut.2004.052282 PMID: 15888789
Johnson V, Volikos E, Halford S, Eftekhar Sadat A, Popat S, Talbot I, Truninger K, Martin J, Jass J, Houlston R, Atkin W, Tomlinson I, and Silver A. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in the hereditary non-polyposis colorectal cancer syndrome. Gut. 2005 Feb;54(2):264-7. DOI: 10.1136/gut.2004.048132 PMID: 15647192
2004
Suraweera N, Zampeli E, Rogers P, Atkin W, Forbes A, Harbord M, Silver A. NCF1 (p47phox) and ncf1 pseudogenes are not associated with inflammatory bowel disease. Inflamm Bowel Dis. 2004 Nov;10(6):758-62.PMID: 15626894
Renehan A, Atkin W, O’Dwyer ST, Shalet SM. The effect of cigarette smoking use and cessation on serum insulin-like growth factors. Br J Cancer. 2004 Oct 18;91(8):1525-31. DOI: 10.1038/sj.bjc.6602150 PMID: 15354219
Wardle J, McCaffery K, Nadel M, Atkin W. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med. 2004 Jul;59(2):249-61.PMID: 15110417
Ferraris R, Senore C, Fracchia M, Sciallero S, Bonelli L, Atkin WS, Segnan N and the SCORE working group Italy. Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screening population. Eur J Cancer. 2004 Jan;40(2):245-52. PMID: 14728939
Taylor SA, Halligan S, Burling D, Morley S, Bassett P, Atkin W, Bartram CI. CT colonography: effect of experience and training on reader performance. Eur Radiol. 2004 Jun;14(6):1025-33. Epub 2004 Feb 10.PMID: 14872280
Atkin W, Rogers P, Cardwell C, Cook C, Cuzick J, Wardle J, Edwards R. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology. 2004 May;126(5):1247-56.PMID: 15131784
2003
Taylor SA, Halligan S, Saunders BP, Morley S, Riesewyk C, Atkin W, Bartram CI. Use of multidetector-row CT colonography for detection of colorectal neoplasia in patients referred via the United Kingdom government ‘two-week-wait’ initiative. Clin Radiol. 2003 Nov;58(11):855-61. PMID: 14581009
Miles A, Wardle J, Atkin W. Receiving a screen-detected diagnosis of cancer: the experience of participants in the UK flexible sigmoidoscopy trial. Psychooncology. 2003 Dec;12(8):784-802.PMID: 14681952
Taylor SA, Halligan S, O’Donnell C, Morley S, Mistry H, Saunders BP, Vance M, Bassett P, Windsor A, Stern Y, Bethel H, Atkin W, Bartram CI. Cardiovascular effects at multi-detector row CT colonography compared with those at conventional endoscopy of the colon. Radiology. 2003 Dec;229(3):782-90.PMID: 14657316
Thompson MR, Heath I, Ellis BG, Swarbrick ET, Faulds-Wood L, Atkin WS. Identifying and managing patients at low risk of bowel cancer in general practice. BMJ. 2003 Aug 2;327(7409):263-5. DOI: 10.1136/bmj.327.7409.263 PMID: 12896939
Halligan S, Marshall M, Taylor S, Bartram C, Bassett P, Cardwell C, Atkin W. Observer Variation in detection of colorectal neoplasia on double-contrast barium enema: implications for colorectal cancer screening and training. Clin Radiol. 2003 Dec;58(12):948-54; discussion 945-7. PMID: 14654027
Taylor SA, Halligan S, Bartram CI, Morgan PR, Talbot IC, Fry N, Saunders BP, Khosraviani K, Atkin W. Multi-detector row CT colonography: effect of collimation, pitch, and orientation on polyp detection in a human colectomy specimen. Radiology. 2003 Oct;229(1):109-18.PMID: 14519872
Taylor SA, Halligan S, Vance M, Morley S, Windsor A, Atkin W, Bartram CI. Use of multidetector-row CT colonography prior to flexible sigmoidoscopy in the investigation of rectal bleeding. Br J Surg. 2003 Sep;90(9):1163-4. DOI: 10.1002/bjs.4211 PMID: 12945088
Taylor SA, Halligan S, Goh V, Morley S, Bassett P, Atkin W, Bartram CI. Optimizing colonic distention for multi-detector row CT colonography: effect of hyoscine butylbromide and rectal balloon catheter. Radiology. 2003 Oct;229(1):99-108. Epub 2003 Aug 27.PMID: 12944595
Taylor SA, Halligan S, Goh V, Morley S, Atkin W, CI Bartram. Optimising bowel preparation for Multidetector Row CT colonography: Effect of Citramag and Picolax. Clin Radiol. 2003;58:723-32. PMID: 12943647
Miles A, Wardle J, McCaffery K, Williamson S, Atkin W. The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):651-5. No abstract available.PMID: 12869406
Adams C, Cardwell C, Cook C, Edwards R, Atkin WS, Morton DG. Effect of hysterectomy status on polyp detection rates at screening flexible sigmoidoscopy. Gastrointest Endosc. 2003 Jun;57(7):848-53.PMID: 12776031
Whynes DK, Frew EJ, Edwards R, Atkin WS. Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care. 2003 Spring;19(2):384-95.PMID: 12862195
Jaeger EEM, Woodford-Richens KL, Lockett M, Rowan AJ, Sawyer EJ, Heinimann K, Rozen P, Murday VA, Whitelaw SC, Ginsberg A, Atkin WS, Lynch HT, Southey MC, Debinski H, Eng C, Bodmer WF, Talbot IC, Hodgson SV, Thomas HJW, Tomlinson IPM. An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet. 2003 May;72(5):1261-7. DOI: 10.1086/375144 PMID: 12696020
Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, Atkin W. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol. 2003 Jan;22(1):99-105.PMID: 12558207
Atkin W. Options for screening for colorectal cancer. Scand J Gastroenterol Suppl. 2003;(237):13-6. PMID: 12797674
Wardle J, Williamson S, Sutton S, Biran A, McCaffery K, Cuzick J, Atkin W. Psychological impact of colorectal cancer screening. Health Psychol. 2003 Jan;22(1):54-9.PMID: 12558202
2002
Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M, Atkin WS; SCORE Working Group–Italy. Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy”–SCORE. J Natl Cancer Inst. 2002 Dec 4;94(23):1763-72.PMID: 12464648
McCaffery K, Wardle J, Nadel M, Atkin W. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen. 2002;9(3):104-8. DOI: 10.1136/jms.9.3.104 PMID: 12370320
Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut. 2002 Oct;51 Suppl 5:V6-9. PMID: 12221031
Brooker JC, Saunders BP, Shah SG, Thapar CJ, Thomas HJ, Atkin WS, Cardwell CR, Williams CB. Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial. Gastrointest Endosc. 2002 Sep;56(3):333-8.PMID: 12196768
Leuratti C, Watson MA, Deag EJ, Welch A, Singh R, Gottschalg E, Marnett LJ, Atkin W, Day NE, Shuker DE, Bingham SA Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas. Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):267-73.PMID: 11895876
Atkin WS, Cook C, Cuzick J, Edwards R, Northover JMA, Wardle J and the UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer; baseline findings of a UK multicentre randomised trial. Lancet. 2002 Apr 13;359(9314):1291-300. DOI: 10.1016/S0140-6736(02)08268-5 PMID: 11965274
2001
Atkin WS, Edwards R, Wardle J, Northover JMA, Sutton S, Hart AR, Williams CB, Cuzick J. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen. 2001;8(3):137-44. DOI: 10.1136/jms.8.3.137 PMID: 11678553
Renehan AG, Painter JE, Atkin WS, Shalet SM, O’Dwyer ST. High-risk colorectal adenomas and serum insulin-like growth factors. Br J Surg. 2001 Jan;88(1):107-13. DOI: 10.1046/j.1365-2168.2001.01645.x PMID: 11136321
Hanson JM, Atkin WS, Cunliffe WJ, Browell DA, Griffith CDM, Varma JS, Plusa SM. Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination. Dis Colon Rectum. 2001 Nov;44(11):1706-8. PMID: 11711746
McCaffery K, Borrill J, Williamson S, Taylor T, Sutton S, Atkin W, Wardle J. Declining the offer of flexible sigmoidoscopy screening for bowel cancer: a qualitative investigation of the decision-making process. Soc Sci Med. 2001 Sep;53(5):679-91. PMID: 11478546
2000
Lamlum H, Al Tassan N, Jaeger E, Frayling L, Sieber O, Reza FB, Eckert M, Rowan A, Barclay E, Atkin W, Williams C, Gilbert J, Cheadle J, Bell J, Houlston R, Bodmer W, Sampson J, Tomlinson I. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet. 2000 Sep 22;9(15):2215-21. PMID: 11001924
Wardle J, Sutton S, Williamson S, Taylor T, McCaffery K, Cuzick J, Hart A, Atkin WS. Psychosocial influences on older adults interest in participating in bowel cancer screening. Prev Med. 2000 Oct;31(4):323-34. DOI: 10.1006/pmed.2000.0725 PMID: 11006057
Sutton S, Wardle J, Taylor T, McCaffery K, Williamson S, Edwards R, Cuzick J, Hart A, Northover J, Atkin W. Predictors of attendance in the UK flexible sigmoidoscopy screening trial. J Med Screen. 2000;7(2):99-104. DOI: 10.1136/jms.7.2.99 PMID: 11002451
Rex D, Atkin W, Hoff G, Waye J. The flexible sigmoidoscope. Gastrointest Endosc. 2000 Oct;52(4):587-9. PMID: 11023594
Renehan AG, Painter JE, O’Halloran D, Atkin WS, Potten CS, O’Dwyer ST, Shalet SM. Circulating insulin-like growth factor (IGF)-II and colorectal adenomas. J Clin Endocrinol Metab. 2000 Sep;85(9):3402-8. DOI: 10.1210/jcem.85.9.6770 PMID: 10999841
Martin JP, Sexton BF, Saunders BP, Atkin WS. Inhaled patient-administered nitrous oxide/oxygen mixture does not impair driving ability when used as analgesia during screening flexible sigmoidoscopy. Gastrointest Endosc. 2000 Jun;51(6):701-3. PMID: 10840303
Taylor T, Williamson S, Wardle J, Borrill. J, Sutton S, Atkin W. Acceptability of flexible sigmoidoscopy screening in older adults in the UK. J Med Screen. 2000;7(1):38-45. DOI: 10.1136/jms.7.1.38 PMID: 10807146
Atkin WS, Hart A, Edwards R, Cook C, Wardle J, McIntyre P, Aubrey R, Baron C, Sutton S, Cuzick J, Senapati A, Northover JMA. Single blind, randomised trial of efficacy and acceptability of oral picolax versus self-administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening. BMJ. 2000 Jun 3;320(7248):1504-8 PMID: 10834891
1999
Bell GD, Atkin WS, Painter J, Rowland RS, Dogramadzi S. Increasing the reach of flexible sigmoidoscopy. Endoscopy. 1999 Nov;31(9):835-6. PMID: 10604628
Frew E, Wolstenholme JL, Atkin WS, Whynes DK. Estimating time and travel costs incurred in clinic-based screening: flexible sigmoidoscopy screening for colorectal cancer. J Med Screen. 1999;6(3):119-23. DOI: 10.1136/jms.6.3.119 PMID: 10572841
Wardle J, Taylor T, Sutton S, Atkin WS. Does publicity about cancer screening raise fear of cancer? Randomised trial of the psychological effect of information about cancer screening. BMJ. 1999 Oct 16;319(7216):1037-8. PMID: 10521195
1998
Hart AR, Kudo S, Mackay EH, Mayberry JF, Atkin WS. Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes. Gut. 1998 Aug;43(2):229-31. PMID: 10189849
Meijer GA, Back JP, Talbot IC, Atkin WS, Meuwissen SG. Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenomas using quantitative pathological features: a case-control study. J Pathol. 1998 Jan;184(1):63-70. DOI: 10.1002/(SICI)1096-9896(199801)184:13.0.CO;2-D PMID: 9582529
Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JMA. Uptake, yield of neoplasia and adverse effects of flexible sigmoidoscopy. Gut. 1998 Apr;42(4):560-5. PMID: 9616321
Atkin W. Flexible sigmoidoscopy as a mass screening tool. Eur J Gastroenterol Hepatol. 1998 Mar;10(3):219-23. PMID: 9585024
1996
Senore C, Segnan N, Rossini FP, Ferraris R, Cavallero M, Coppola F, Pennazio F, Atkin WS. Screening for colorectal cancer by once-only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen. 1996;3(2):72-8. DOI: 10.1177/096914139600300205 PMID: 8849763
1995
Saunders BP, Elsby B, Boswell AM, Atkin WS, Williams CB. Intravenous anti-spasmodic and patient-controlled analgesia are of benefit for screening flexible sigmoidoscopy. Gastrointest Endosc. 1995 Aug;42(2):123-7. PMID: 7590046
Gaglia P, Atkin WS, Whitelaw S, Talbot IC, Williams CB, Northover JMA, Hodgson SV. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. Gut. 1995 Mar;36(3):385-90. PMID: 7698698
1993
Atkin WS, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by ‘once-only’ sigmoidoscopy. Lancet. 1993 Mar 20;341(8847):736-40 PMID: 8095636
1992
Atkin WS, Morson BC, Cuzick JC. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992 Mar 5;326(10):658-62. DOI: 10.1056/NEJM199203053261002 PMID: 1736104
1991
Williams CB, Talbot IC, Atkin WS. Adenoma screening and colorectal cancer. BMJ. 1991 Oct 12;303(6807):925 PMID: 1933017
1987
Sasaki O, Atkin WS, Jass JR. Mucinous carcinoma of the rectum. Histopathology. 1987 Mar;11(3):259-72. PMID: 2828216
Goh HS, Atkin WS, Northover JMA, Jass JR. Value of flow-cytometric determination of ploidy as a guide to prognosis in operable rectal cancer- a multivariate analysis. Int J Colorectal Dis. 1987 Feb;2(1):17-21. PMID: 3598327
1986
Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd IP. The grading of rectal cancer-historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986 May;10(5):437-59. PMID: 3721406